Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tocolion Benta
- Development stage
- Unknown
- Lead developer
- PharmaVitae
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tocolion Benta is an oral generic formulation of vitamin E (specifically alpha-tocopherol acetate) developed and marketed by Benta Lyon. It is approved for the treatment of vitamin E deficiency, which can occur due to malabsorption syndromes, genetic disorders, or other underlying conditions. Vitamin E acts as a potent fat-soluble antioxidant, protecting cell membranes from oxidative damage caused by free radicals, and plays a crucial role in maintaining neurological, cardiovascular, and immune health. Tocolion Benta is supplied as 500 mg soft capsules.
- Brand names
- TocolionTocolion Benta
- Other names
- alpha-tocopherol acetatealpha-tocopheryl acetatetocopherolvitamin E
Beyond the preview
Go deeper on Tocolion Benta.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tocolion Benta.